 |
| |
|
|
FDA approval of a drug is often a long process, but if the results of a study show the drug to be effective, a study drug may become available, or FDA-approved soon after a study has ended. Sometimes, open-label (everyone in the study is on the study drug) extensions follow a research study.
|
| |
|
| |
|
| |
©
Copyright 2004 Diablo Clinical Research. No part of this website
may be reproduced without express written permission. |
| |
|
|
|
|
